Markus Klemke
Bremerhaven, HB, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Does miR-371a-3p Regulate HMGA2 via Let-7, and Could Combined Targeting Further Increase Cisplatin Sensitivity in Embryonal Carcinoma?
Journal: Andrology
Published: February 03, 2026
Biomarker microRNA-371a-3p - expression in malignancies other than germ-cell tumours.
Journal: Journal of cancer research and clinical oncology
Published: December 02, 2024
Expression of the novel serum biomarker of testicular germ cell tumours miR-371a-3p in serum of pregnant women: a case-control study.
Journal: European journal of medical research
Published: October 07, 2024
Detection of Recurrence through microRNA-371a-3p Serum Levels in a Follow-up of Stage I Testicular Germ Cell Tumors in the DRKS-00019223 Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 09, 2023
Testicular neoplasms: the interrelationships of serum levels of microRNA-371a-3p (M371) and classical tumor markers with histology, clinical staging, and age-a statistical analysis.
Journal: Journal of cancer research and clinical oncology
Published: January 11, 2023
Serum Levels of MicroRNA-371a-3p (M371) Can Predict Absence or Presence of Vital Disease in Residual Masses After Chemotherapy of Metastatic Seminoma.
Journal: Frontiers in oncology
Published: March 04, 2022
HMGA2 expression in the PC-3 prostate cancer cell line is autonomous of growth factor stimulation.
Journal: Anticancer research
Published: July 31, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026